Oncology Institute (DFPH) Return on Equity (2020 - 2026)

Oncology Institute (DFPH) has 7 years of Return on Equity data on file, last reported at 0.03% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity rose 18.0% year-over-year to 0.03%; the trailing twelve-month figure through Mar 2026 stood at 0.03% (up 18.0% YoY), and the FY2025 full-year result was 0.1%, up 12.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.03%, down from 0.04% in the prior quarter.
• Across five years, Return on Equity topped out at 0.34% in Q2 2025 and bottomed at 0.15% in Q1 2025.
• The 5-year median for Return on Equity is 0.0% (2023), against an average of 0.01%.
• Peak annual rise in Return on Equity reached 36 bps in 2025, while the deepest fall reached 13 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2022, then plunged by 106585 bps to 0.01% in 2023, then sank by 426 bps to 0.07% in 2024, then surged by 164 bps to 0.04% in 2025, then sank by 37 bps to 0.03% in 2026.
• The last three Return on Equity figures came in at 0.03% (Q1 2026), 0.04% (Q4 2025), and 0.06% (Q3 2025), per Business Quant data.

Peer Comparison